A detailed history of Jacobi Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Jacobi Capital Management LLC holds 124,002 shares of PFE stock, worth $3.32 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
124,002
Previous 121,987 1.65%
Holding current value
$3.32 Million
Previous $3.41 Million 5.13%
% of portfolio
0.28%
Previous 0.3%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $55,815 - $63,250
2,015 Added 1.65%
124,002 $3.59 Million
Q2 2024

Aug 09, 2024

BUY
$25.26 - $29.6 $21,546 - $25,248
853 Added 0.7%
121,987 $3.41 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $8,388 - $9,632
324 Added 0.27%
121,134 $3.36 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $102,011 - $132,501
3,904 Added 3.34%
120,810 $3.48 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $141,388 - $165,269
4,406 Added 3.92%
116,906 $3.88 Million
Q2 2023

Aug 08, 2023

BUY
$36.12 - $41.79 $33,844 - $39,157
937 Added 0.84%
112,500 $4.13 Million
Q1 2023

May 05, 2023

SELL
$39.39 - $51.28 $151,533 - $197,274
-3,847 Reduced 3.33%
111,563 $4.55 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $235,052 - $306,835
5,630 Added 5.13%
115,410 $5.92 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $170,707 - $208,391
3,901 Added 3.68%
109,780 $4.8 Million
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $65,886 - $78,120
-1,416 Reduced 1.32%
105,879 $5.55 Million
Q1 2022

May 06, 2022

BUY
$45.75 - $56.69 $76,539 - $94,842
1,673 Added 1.58%
107,295 $5.56 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $64,293 - $95,305
1,556 Added 1.5%
105,622 $6.24 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $68,883 - $88,487
1,755 Added 1.72%
104,066 $4.48 Million
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $25,280 - $28,638
704 Added 0.69%
102,311 $4.01 Million
Q1 2021

May 11, 2021

BUY
$33.49 - $37.77 $134,730 - $151,948
4,023 Added 4.12%
101,607 $3.68 Million
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $322,148 - $409,640
-9,625 Reduced 8.98%
97,584 $3.61 Million
Q3 2020

Oct 30, 2020

BUY
$31.75 - $37.25 $619,982 - $727,380
19,527 Added 22.27%
107,209 $3.98 Million
Q2 2020

Aug 04, 2020

BUY
$30.12 - $36.54 $2.35 Million - $2.85 Million
77,913 Added 797.55%
87,682 $3.73 Million
Q2 2020

Jul 27, 2020

SELL
$30.12 - $36.54 $2.92 Million - $3.54 Million
-97,007 Reduced 90.85%
9,769 $3.73 Million
Q1 2020

Apr 24, 2020

BUY
$27.03 - $38.62 $80,116 - $114,469
2,964 Added 2.86%
106,776 $3.59 Million
Q4 2019

Feb 03, 2020

BUY
$32.92 - $37.36 $141,292 - $160,349
4,292 Added 4.31%
103,812 $4.08 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $6,887 - $8,931
-212 Reduced 0.21%
99,520 $3.59 Million
Q2 2019

Aug 07, 2019

BUY
$36.98 - $41.52 $1.08 Million - $1.21 Million
29,202 Added 41.4%
99,732 $4.32 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $232,275 - $255,192
6,194 Added 9.63%
70,530 $3 Million
Q4 2018

Feb 11, 2019

BUY
$38.47 - $43.86 $574,010 - $654,435
14,921 Added 30.2%
64,336 $2.81 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $44,983 - $54,562
1,305 Added 2.71%
49,415 $2.18 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $126,379 - $134,733
3,832 Added 8.65%
48,110 $1.75 Million
Q1 2018

May 03, 2018

BUY
$31.91 - $37.02 $255,184 - $296,048
7,997 Added 22.04%
44,278 $1.55 Million
Q4 2017

Feb 05, 2018

BUY
$33.26 - $35.29 $3,891 - $4,128
117 Added 0.32%
36,281 $1.32 Million
Q3 2017

Nov 02, 2017

BUY
$31.0 - $34.15 $24,986 - $27,524
806 Added 2.28%
36,164 $1.31 Million
Q2 2017

Aug 10, 2017

BUY
N/A
35,358
35,358 $1.18 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Jacobi Capital Management LLC Portfolio

Follow Jacobi Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.